Pro Medicus Limited (ASX:PME)
Australia
· Delayed Price · Currency is AUD | Market Cap | 13.12B |
| Revenue (ttm) | 240.57M |
| Net Income (ttm) | 234.70M |
| Shares Out | 104.47M |
| EPS (ttm) | 2.24 |
| PE Ratio | 56.02 |
| Forward PE | 73.06 |
| Dividend | 0.64 (0.49%) |
| Ex-Dividend Date | Feb 26, 2026 |
| Volume | 363,861 |
| Average Volume | 623,962 |
| Open | 123.10 |
| Previous Close | 130.00 |
| Day's Range | 121.10 - 127.92 |
| 52-Week Range | 107.75 - 336.00 |
| Beta | 0.60 |
| RSI | 37.53 |
| Earnings Date | Feb 12, 2026 |
About Pro Medicus
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and commu... [Read more]
Financial Performance
In fiscal year 2025, Pro Medicus's revenue was 212.98 million, an increase of 31.88% compared to the previous year's 161.50 million. Earnings were 115.22 million, an increase of 39.16%.
Financial StatementsNews
Pro Medicus Limited (PMDIY) Q2 2026 Earnings Call Transcript
Pro Medicus Limited (PMDIY) Q2 2026 Earnings Call Transcript
Pro Medicus Ltd (PMCUF) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic Growth
Pro Medicus Ltd (PMCUF) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic Growth
Pro Medicus H1 Profit, Revenue Climb
(RTTNews) - Pro Medicus Limited (PME.AX), a health imaging company, on Thursday reported higher profit for the first half, driven mainly by higher revenue and a significant increase in fair value move...
Billionaire Sam Hupert says AI will not terminate his business
Pro Medicus shares sank 24 per cent on Thursday after a solid profit result failed to convince investors it would be immune to disruption from AI.
Half Year 2026 Pro Medicus Ltd Earnings Call Transcript
Half Year 2026 Pro Medicus Ltd Earnings Call Transcript
Pro Medicus Limited (PMDIY) Shareholder/Analyst Call Transcript
Pro Medicus Limited (OTCPK:PMDIY) Shareholder/Analyst Call November 23, 2025 6:00 PM EST Company Participants Peter Kempen Sam Hupert - Co-Founder, CEO, MD & Executive Director Danny English - Financi...
Pro Medicus Limited (PMCUF) Q4 2025 Earnings Call Transcript
Pro Medicus Limited (OTCPK:PMCUF) Q4 2025 Earnings Conference Call August 13, 2025 9:00 PM ET Company Participants Clayton James Hatch - Chief Financial Officer Sam Aaron Hupert - Co-Founder, CEO, MD ...
Pro Medicus Limited (PMCUF) Q2 2025 Earnings Call Transcript
Pro Medicus Limited (OTCPK:PMCUF) Q2 2025 Results Conference Call February 12, 2025 7:00 PM ET Company Participants Sam Hupert - Chief Executive Officer Clayton Hatch - Chief Financial Officer Confere...
Pro Medicus Limited (PMCUF) Q4 2024 Earnings Call Transcript
Pro Medicus Limited (OTCPK:PMCUF) Q4 2024 Earnings Conference Call August 13, 2024 9:00 PM ET Company Participants Sam Hupert - CEO Clayton Hatch - CFO Conference Call Participants Garry Sherriff - RB...
Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript
Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript
Pro Medicus Limited (PMCUF) Q2 2023 Earnings Call Transcript
Pro Medicus Limited (OTCPK:PMCUF) Q2 2023 Earnings Conference Call February 14, 2023 7:00 PM ET Company Participants Sam Hupert - Chief Executive Officer Clayton Hatch - Chief Financial Officer Confer...
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q4 2022 Results - Earnings Call Transcript
Pro Medicus Limited (OTCPK:PMCUF) Q4 2022 Earnings Conference Call August 17, 2022 9:00 PM ET Company Participants Sam Hupert - Chief Executive Officer and Managing Director Clayton Hatch - Chief Fina...
Pro Medicus Limited (PMCUF) CEO Sam Hupert On Q2 2022 Results - Earnings Call Transcript
ro Medicus Limited (OTCPK:PMCUF) Q2 2022 Earnings Conference Call February 15, 2022 7:00 PM ET Company Participants Sam Hupert - Chief Executive Officer and Managing Director Clayton Hatch - Chief Fin...
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Half Year 2022 Results - Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Half Year 2022 Results - Earnings Call Transcript
Pro Medicus' (PMCUF) CEO Sam Hupert on Q4 2021 Results - Earnings Call Transcript
Pro Medicus' (PMCUF) CEO Sam Hupert on Q4 2021 Results - Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q2 2021 Results - Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q2 2021 Results - Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q4 2020 Results - Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q4 2020 Results - Earnings Call Transcript
Pro Medicus: Healthcare IT Developer With Impressive Growth Story
Pro Medicus: Healthcare IT Developer With Impressive Growth Story
Pro Medicus: An Emerging Star In Digital Healthcare
Pro Medicus has been an exceptionally strong performer for my high growth, Project $1M portfolio, returning more than 250% over the last 3 years .